News & Videos - RESINCO CAP PARTNERS

You are currently viewing all stock exchange news of the financial instrument RESINCO CAP PARTNERS regarding all markets in all languages.

RESINCO CAP PARTNERS > News EQS Group published a news.

DGAP-News: Resinco Capital Partners Inc.: Resinco Capital Partners finanziert an der Oxford-Universität ein Stammzellenprojekt • • EQS Group • Stocks

DGAP-News: Resinco Capital Partners Inc. / Schlagwort(e): Private Equity Resinco Capital Partners Inc.: Resinco Capital Partners finanziert an der Oxford-Universität ein Stammzellenprojekt 18.03.2019 / 09:13 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Resinco Capital Partners finanziert an der Oxford-Universität ein Stammzellenprojekt Vancouver, British Columbia. 15. März 2019. Resinco Capital Partners Inc. (CSE: RIN , OTC Pink: RSCZF , FRANKFURT: L6V1 ) (das...

Thank you

RESINCO CAP PARTNERS > News EQS Group published a news.

DGAP-News: Resinco Capital Partners Funds Stem Cell Project at Oxford University • • EQS Group • Stocks

DGAP-News: Resinco Capital Partners Inc. / Key word(s): Miscellaneous Resinco Capital Partners Funds Stem Cell Project at Oxford University 15.03.2019 / 21:48 The issuer is solely responsible for the content of this announcement. Vancouver, British Columbia--(Newsfile Corp. - March 15, 2019) - Resinco Capital Partners Inc. (CSE: RIN ) (OTC Pink: RSCZF ) (FSE: L6V1 ) (the " Company " or " Resinco "), a global investment company which specializes in providing early-stage financing to private and...

Thank you

RESINCO CAP PARTNERS > News Newsfile Corp. published a news.

Resinco Capital Partners Funds Stem Cell Project at Oxford University • • Newsfile Corp. • Stocks

Vancouver, British Columbia--(Newsfile Corp. - March 15, 2019) - Resinco Capital Partners Inc. (CSE: RIN ) (OTC Pink: RSCZF ) (FSE: L6V1 ) (the " Company " or " Resinco "), a global investment company which specializes in providing early-stage financing to private and public companies, is pleased to announce funding for a project at the University of Oxford in the laboratory of Professor Jagdeep Nanchahal. Through the Company's wholly owned subsidiary ReFormation Pharmaceuticals Corp....

Thank you

RESINCO CAP PARTNERS > News EQS Group published a news.

Resinco Capital Partners Inc.: Verstärkung des Managements durch weltweit führenden Immunologen - Resinco bestens für den Cannabis Markt 2.0 gerüstet • • EQS Group • Stocks

DGAP-Media / 06.02.2019 / 07:37 Anlass des Berichts: Erstempfehlung Unternehmen: Resinco Capital Partners (WKN A2H52W) Kursziel mittelfristig: 0,50 EUR Kursziel langfristig: 1,00 EUR Verstärkung des Managements durch weltweit führenden Immunologen - Resinco bestens für den Cannabis Markt 2.0 gerüstet Mit heutiger News gibt Resinco Capital Partners (WKN A2H52W) die Ernennung von Sir Marc Feldman in den Beirat des Unternehmens bekannt. Resinco hat vor kurzem das von Mr. Feldman mitbegründete...

Thank you

RESINCO CAP PARTNERS > News EQS Group published a news.

DGAP-News: Resinco Capital Partners Inc.: Resinco Capital Partners gibt Bestellung von Sir Marc Feldman in den Beirat bekannt • • EQS Group • Stocks

DGAP-News: Resinco Capital Partners Inc. / Schlagwort(e): Personalie Resinco Capital Partners Inc.: Resinco Capital Partners gibt Bestellung von Sir Marc Feldman in den Beirat bekannt 06.02.2019 / 07:32 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Resinco Capital Partners gibt Bestellung von Sir Marc Feldman in den Beirat bekannt Vancouver, British Columbia. 06. Februar 2019. Resinco Capital Partners Inc. (CSE: RIN , OTC: RSCZF , FRANKFURT: L6V1 ) (das "...

Thank you

RESINCO CAP PARTNERS > News EQS Group published a news.

DGAP-News: Resinco Capital Partners Announces the Appointment of Sir Marc Feldmann to Advisory Board • • EQS Group • Stocks

DGAP-News: Resinco Capital Partners Inc. / Key word(s): Miscellaneous Resinco Capital Partners Announces the Appointment of Sir Marc Feldmann to Advisory Board 06.02.2019 / 06:01 The issuer is solely responsible for the content of this announcement. Vancouver, British Columbia--(Newsfile Corp. - February 6, 2019) - Resinco Capital Partners Inc. (CSE: RIN ) (OTC Pink : RSCZF ) (FSE : L6V1 ) (the ' Company ' or ' Resinco ') is pleased to announce that the Company has appointed pioneer and...

Thank you

RESINCO CAP PARTNERS > News Newsfile Corp. published a news.

Resinco Capital Partners Announces the Appointment of Sir Marc Feldmann to Advisory Board • • Newsfile Corp. • Stocks

Vancouver, British Columbia--(Newsfile Corp. - February 6, 2019) - Resinco Capital Partners Inc. (CSE: RIN ) (OTC Pink : RSCZF ) (FSE : L6V1 ) (the " Company " or " Resinco ") is pleased to announce that the Company has appointed pioneer and trailblazer of modern immunology, Sir Marc Feldmann, to its Advisory Board after fully acquiring his company, ReFormation Pharmaceuticals Corp, a medical cannabis company developing innovative, first-in-class therapies to repair vital organs and stem cells...

Thank you

RESINCO CAP PARTNERS > News EQS Group published a news.

Resinco Capital Partners Inc.: 100 % Übernahme perfekt - Cannabis Pharmaunternehmen der Universität Oxford mit revolutionärer Entdeckung - Aktie vor starkem Anstieg! • • EQS Group • Stocks

DGAP-Media / 16.01.2019 / 08:45 Anlass des Berichts: Erstempfehlung Unternehmen: Resinco Capital Partners (WKN A2H52W) Kursziel mittelfristig: 0,50 EUR Kursziel langfristig: 1,00 EUR 100 % Übernahme perfekt - Cannabis Pharmaunternehmen der Universität Oxford mit revolutionärer Entdeckung - Aktie vor starkem Anstieg! Wir stellten Ihnen in unserer kürzlichen Erstempfehlung das aussichtsreiche Cannabis Pharmamunternehmen Resinco Capital Partners (WKN A2H52W) vor. Mit heutiger News vermeldete...

Thank you

RESINCO CAP PARTNERS > News EQS Group published a news.

DGAP-News: Resinco Capital Partners Inc.: Resinco Capital Partners meldet Restakquisition der ReFormation Pharmaceuticals Corp. • • EQS Group • Stocks

DGAP-News: Resinco Capital Partners Inc. / Schlagwort(e): Firmenübernahme Resinco Capital Partners Inc.: Resinco Capital Partners meldet Restakquisition der ReFormation Pharmaceuticals Corp. 16.01.2019 / 07:22 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Resinco Capital Partners meldet Restakquisition der ReFormation Pharmaceuticals Corp. ReFormation entwickelt ein neuartiges Therapeutikum zur Reparatur lebenswichtiger Organe durch Kombination von Cannabinoiden...

Thank you

RESINCO CAP PARTNERS > News EQS Group published a news.

DGAP-News: Resinco Capital Partners Announces Remaining Acquisition of ReFormation Pharmaceuticals Corp • • EQS Group • Stocks

DGAP-News: Resinco Capital Partners Inc. / Key word(s): Miscellaneous Resinco Capital Partners Announces Remaining Acquisition of ReFormation Pharmaceuticals Corp 16.01.2019 / 06:50 The issuer is solely responsible for the content of this announcement. Vancouver, British Columbia--(Newsfile Corp. - January 16, 2019) - Resinco Capital Partners Inc. (CSE: RIN) ( OTC Pink : RSCZF) ( FSE : L6V1 ) (the ' Company ' or ' Resinco ') is pleased to announce that the Company has entered into a definitive...

Thank you

RESINCO CAP PARTNERS > News Newsfile Corp. published a news.

Resinco Capital Partners Announces Remaining Acquisition of ReFormation Pharmaceuticals Corp • • Newsfile Corp. • Stocks

Vancouver, British Columbia--(Newsfile Corp. - January 16, 2019) - Resinco Capital Partners Inc. (CSE: RIN) ( OTC Pink : RSCZF) ( FSE : L6V1 ) (the " Company " or " Resinco ") is pleased to announce that the Company has entered into a definitive agreement to acquire the remaining 51% of ReFormation Pharmaceuticals Corp, a medical cannabis company developing innovative, first-in-class therapies to repair vital organs and stem cells by combining cannabinoids and an endogenous trigger of repair....

Thank you

RESINCO CAP PARTNERS > News EQS Group published a news.

Resinco Capital Partners Inc.: Unglaubliche Rendite-Chance - Oxford Professor erforscht neue Cannabis Heilmittel! Bereits jetzt in den Cannabismarkt 2.0 einsteigen! • • EQS Group • Stocks

DGAP-Media / 15.01.2019 / 08:10 Anlass des Berichts: Erstempfehlung Unternehmen: Resinco Capital Partners (WKN A2H52W) Kursziel mittelfristig: 0,50 EUR Kursziel langfristig: 1,00 EUR Unglaubliche Rendite-Chance - Oxford Professor erforscht neue Cannabis Heilmittel! Bereits jetzt in den Cannabismarkt 2.0 einsteigen! Am 17. Oktober 2018 fiel der Startschuss für einen der größten neuen Märkte in den westlichen Industrieländern. Genau an diesem Tag trat in Kanada das Gesetz zur vollständigen...

Thank you

RESINCO CAP PARTNERS > News EQS Group published a news.

DGAP-News: Resinco Capital Partners Inc.: erwirbt 49 % des Cannabis-Pharmaunternehmens ReFormation Pharmaceuticals Corp • • EQS Group • Stocks

DGAP-News: Resinco Capital Partners Inc. / Schlagwort(e): Expansion Resinco Capital Partners Inc.: erwirbt 49 % des Cannabis-Pharmaunternehmens ReFormation Pharmaceuticals Corp 23.10.2018 / 08:57 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Resinco Capital Partners erwirbt 49 % des Cannabis-Pharmaunternehmens ReFormation Pharmaceuticals Corp 23. Oktober 2018. - Vancouver, British Columbia. - Resinco Capital Partners Inc. (CSE: RIN) (das "Unternehmen" oder...

Thank you